This Sarepta Therapeutics Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Analyst Downgrades: Several Wall Street analysts have downgraded their ratings on various stocks, including Packaging Corporation of America (from Buy to Hold), Sarepta Therapeutics (from Neutral to Sell), and Angi Inc. (from Market Outperform to Market Perform).
Price Target Adjustments: Along with downgrades, analysts have also lowered price targets for these companies, with notable reductions for Sarepta Therapeutics from $40 to $10 and PROS Holdings from $27 to $18.
Trade with 70% Backtested Accuracy
Analyst Views on ANGI
About ANGI
About the author

- Market Uncertainty Intensifies: The U.S. market faces increased volatility in early 2026 due to trade threats from the Trump administration and rising geopolitical risks, which diminishes investor confidence and elevates the importance of value investing.
- Positive Outlook for Centerra Gold: Centerra Gold anticipates a 48% year-over-year growth in EPS for 2026, with estimates raised by 17 cents over the past week, reflecting strong performance driven by rising gold prices and effective cost control.
- Strategic Restructuring at Plains GP Holdings: Plains GP Holdings plans to exit the Canadian NGL business, expected to enhance cash flow and financial flexibility, with a projected 27% growth in EPS for 2026 and a 30-cent increase in estimates over the past 60 days.
- Expansion of Angi's Digital Marketplace: Angi forecasts a 36% year-over-year growth in EPS for 2026, with estimates raised by 16 cents in the past week, as it aims to launch a modern AI platform to improve operational efficiency, showcasing its growth potential in essential home services.
- New Board Members: EHS Management welcomes the addition of two new directors to TrueBlue's board, which underscores broad recognition of the issues raised, yet further enhancements are necessary to improve board expertise and shareholder value.
- Experience Gaps: TrueBlue's board lacks seasoned independent staffing executives, digital platform leaders, and capital allocation expertise, which are critical for reversing the company's ongoing loss of market share.
- Shareholder Involvement: EHS Management believes shareholders should determine the level of board refreshment needed to ensure that new candidates' skills can enhance the board's capabilities and independence to better address the challenges facing the company.
- Nominated Candidates: EHS Management has nominated three candidates with extensive industry experience, focusing on staffing excellence, digital transformation, and disciplined capital allocation, aiming to fill the skills gaps on the board and drive long-term success for the company.
- New Board Members: EHS Management welcomes the addition of two new directors to TrueBlue's board, which is seen as a positive change; however, significant gaps in experience and expertise remain, potentially hindering the release of long-term value.
- Need for Board Refresh: EHS points out that TrueBlue has not disclosed which incumbent directors will step down for the new additions, suggesting this may be a tactic by long-tenured directors to maintain the status quo rather than a genuine commitment to change.
- Shareholder Rights: EHS emphasizes that shareholders should have the right to decide the extent of board refreshment needed to ensure that new candidates' skills can enhance the board's capabilities and the quality of independent oversight.
- Nominated Candidates: The three nominees put forward by EHS possess extensive industry experience and focus on staffing excellence, digital transformation, and disciplined capital allocation, aiming to address the skills gaps on the board and drive TrueBlue's long-term success.
Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, helping them stay informed and make timely decisions in the stock market.
Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters, enhancing the trading experience for its users.
Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, indicating a robust network for sharing market intelligence.
Market Winning Tools: Benzinga Pro is designed to equip traders with the tools and information necessary to succeed in the markets daily.
Quarterly Performance: Angi (ANGI) reported $265.63 million in revenue for Q3 2025, a 10.5% decline year-over-year, with an EPS of $0.23 compared to $0.70 a year ago.
Earnings Surprise: The revenue fell short of the Zacks Consensus Estimate of $269.12 million, resulting in a surprise of -1.29%, while the EPS also missed expectations by 30.3%.
Investor Insights: Investors are advised to focus on key metrics that provide deeper insights into the company's performance, beyond just headline revenue and earnings figures.
Research Recommendations: Zacks Investment Research offers insights and recommendations, including a report on the "7 Best Stocks for the Next 30 Days."

Home Selling Dilemma: A 33-year-old man in Arlington, Texas, is navigating the complexities of selling his current home while purchasing a new one.
Renovation Costs Concerns: After spending $20,000 on renovations, he is hesitant about further expenses suggested by his real estate agent, questioning the necessity of additional upgrades like a new driveway.










